Dade Behring set to develop MPO (myeloperoxidase) heart risk test
This article was originally published in Clinica
Executive Summary
Dade Behring is to develop a test for predicting a patient's risk of heart disease or heart attack based on measuring blood levels of a marker called myeloperoxidase (MPO).